2024/09/06 by Iqra Yousaf, Yousaf, Iqra
Biochemistry, Genetics and Molecular Biology · Engineering · Immunology and Microbiology · Medicine · #68Q32 #68Q32 68T05 #68T05 #Advanced Glycation End Products research #Atherosclerosis and Cardiovascular Diseases #Business #Curcumin's Biomedical Applications #Current (fluid) #Diabetes mellitus #Electrical engineering #Endocrinology #Engineering #FOS: Physical sciences #I.2.6 #I.2.8 #Materials Science (cond-mat.mtrl-sci) #Materials science #Medical Physics (physics.med-ph) #Medicine #Metallurgy #Nanoparticle #Nanotechnology #Zinc
paper · pdf · doi:10.48550/arxiv.2409.04486
openalex publication_date 2024/09/06 · openalex created_date 2024/10/22 · openalex updated_date 2026/07/28
This review explores the synthesis, characterization, and therapeutic applications of zinc oxide nanoparticles (ZnO NPs) in the treatment of diabetes mellitus. The study delves into both chemical and green synthesis methods, comparing their impacts on nanoparticle properties. Key characterization techniques such as XRD, FTIR, UV-Vis spectroscopy, and SEM confirm the crystalline structure, optical properties, and morphology of the nanoparticles. ZnO NPs demonstrate significant biological activities, including antibacterial, anti-inflammatory, and antidiabetic effects. These nanoparticles show promise in improving glucose regulation, enhancing insulin sensitivity, and boosting glucose uptake in cells. Despite these benefits, the potential toxicity and long-term effects of ZnO NPs warrant further investigation. Future research should focus on optimizing synthesis methods and conducting comprehensive studies to fully exploit ZnO NPs' potential in diabetes management and other biomedical applications.